It has been proposed that glycolysis inhibition by TIGAR may divert the glycolytic flux to alternative metabolic pathways including the pentose phosphate pathway that generates more reductants such as NADPH and GSH to protect cancer cells from reactive oxygen species, and the hexosamine pathway that promotes nucleotide synthesis for cancer cell proliferation 13,16. This evidence concerns the gene TIGAR and cancer.